STRATA Skin Sciences Inc. (SSKN)
2.95
-0.07 (-2.32%)
At close: Jan 14, 2025, 3:50 PM
2.95
0.00%
After-hours Jan 14, 2025, 03:50 PM EST
undefined% (undefined)
| Bid | 2.95 |
| Market Cap | 12.30M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -2.6 |
| PE Ratio (ttm) | -1.13 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 3.16 |
| Volume | 3,877 |
| Avg. Volume (20D) | 10,111 |
| Open | 3.01 |
| Previous Close | 3.02 |
| Day's Range | 2.95 - 3.08 |
| 52-Week Range | 2.51 - 6.00 |
| Beta | undefined |
About SSKN
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. Its products include XTRAC and Pharos excimer lasers, VTRAC lamp systems, and Ther...
Industry Medical - Devices
Sector Healthcare
IPO Date Nov 3, 2005
Employees 99
Stock Exchange NASDAQ
Ticker Symbol SSKN
Analyst Forecast
According to 1 analyst ratings, the average rating for SSKN stock is "Buy." The 12-month stock price forecast is $undefined, which is a decrease of NaN% from the latest price.
Buy 100.00%
Hold 0.00%
Sell 0.00%
Next Earnings Release
STRATA Skin Sciences Inc. is scheduled to release its earnings on Mar 26, 2025,
during market hours.
Analysts project revenue of $9.03M, reflecting a 3.92% YoY growth and earnings per share of -0.43, making a 7.50% increase YoY.
Analysts project revenue of $9.03M, reflecting a 3.92% YoY growth and earnings per share of -0.43, making a 7.50% increase YoY.
8 months ago ·
Source
-9.05%
Strata Skin Sciences shares are trading lower foll...
Unlock content with
Pro Subscription
8 months ago ·
Source
-16.5%
Strata Skin Sciences shares are trading lower. The company announced a 1-for-10 reverse stock split.
